PSP Investments, Oaktree Capital, and Franklin Templeton Acquire $2 Billion in Hologic Debt Amid Blackstone-TPG Buyout

PSP Investments, Oaktree Capital, and Franklin Templeton Acquire $2 Billion in Hologic Debt Amid Blackstone-TPG Buyout

By USFM•December 3, 2025

A consortium of private credit investors, including PSP Investments, Oaktree Capital Management, and Franklin Templeton, has procured approximately $2 billion in subordinated debt linked to the recent $12.25 billion buyout of Hologic by Blackstone and TPG. This transaction highlights the growing trend of direct lenders participating in leveraged financings to achieve higher yields.

In a significant move in the financial markets, a coalition of private credit investors has acquired around $2 billion of subordinated debt associated with Blackstone and TPG’s recent acquisition of Hologic, a company focused on women’s health medical devices. According to a report by Bloomberg, this debt acquisition is part of a larger $12.25 billion financing package that supports the buyout of Hologic.

The subordinated debt, structured as second-lien debt, is priced attractively at 5 percentage points above the floating-rate benchmark, with an initial offering at 99 cents on the dollar. This deal demonstrates the increasing willingness of direct lenders, such as PSP Investments, Oaktree Capital Management, and Franklin Templeton, to participate in riskier segments of financing, which can offer higher yields compared to traditional bank lending. Other notable participants in this transaction include Palmer Square Capital Management, Oak Hill Advisors, Sona Asset Management, Lord Abbett, and Blackstone’s credit arm.

The strategic rationale behind this acquisition stems from the desire to capitalize on the robust growth potential of Hologic, especially given its focus on women's health, a sector that has seen increasing attention and investment. By backing this buyout, the investors are positioning themselves to benefit from Hologic's future performance as it continues to innovate and expand in a growing market.

As for the timeline, the buyout transaction is expected to close in the near future, although specific dates were not detailed in the filing. Following the completion of the acquisition, stakeholders will likely monitor Hologic's integration into Blackstone and TPG’s portfolio, assessing its operational and financial performance post-acquisition.

The market impact of this transaction could be significant, particularly for shareholders of Hologic as they may see enhanced value creation from the operational synergies realized post-merger. Employees may also experience shifts in company culture and structure as the new ownership settles in. On a broader scale, this deal reflects a growing trend in the financial landscape where private equity firms and direct lenders increasingly collaborate on large leveraged financings.

Lastly, while the transaction is poised to progress, it will still require adherence to regulatory considerations, including any necessary antitrust approvals that may arise as part of the acquisition process. The involvement of multiple financial institutions suggests a thorough evaluation of the deal's implications at various levels of the investment community.